Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation implanted its vision-restoring chip in its first Stargardt disease patient. Max Hodak, former Neuralink president, detailed at TechCrunch Disrupt how the PRIMA system advances toward a novel brain-computer interface. The implant aims to restore sight in patients with retinal degeneration, marking a milestone in the company's BCI development.